INDV-6001 Multiple-Dose Pharmacokinetic Study
- Conditions
- Interventions
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT06576843
- Locations
- 🇺🇸
Chicago Clinical Research Institute Inc., Chicago, Illinois, United States
🇺🇸Artemis Institute for Clinical Research, San Diego, California, United States
🇺🇸Innovative Clinical Research, Inc., Miami Lakes, Florida, United States
Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT06384157
- Locations
- 🇺🇸
Boyett Health Services Inc, Hamilton, Alabama, United States
🇺🇸Elite Clinical Studies, LLC, Phoenix, Arizona, United States
🇺🇸Agile Clinical Research Trials, Atlanta, Georgia, United States
Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants
- First Posted Date
- 2023-08-03
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT05974046
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
Evaluating the SUBLOCADE Treatment Exit Strategy
- Conditions
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT05878210
- Locations
- 🇺🇸
Neighborhood Healthcare-Institute of Health, Escondido, California, United States
🇺🇸Comprehensive Addiction Medicine, Portland, Maine, United States
🇺🇸Thryv Clinical Study, LLC, Dearborn, Michigan, United States
SUBLOCADE Long-term Outcomes
- Conditions
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 1200
- Registration Number
- NCT05860959
- Locations
- 🇺🇸
SHMG Center for Integrative Medicine, Grand Rapids, Michigan, United States
🇺🇸North Mississippi Medical Center, Tupelo, Mississippi, United States
🇺🇸United Health Services, Binghamton, New York, United States
Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations
- Conditions
- Interventions
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 88
- Registration Number
- NCT05704543
- Locations
- 🇺🇸
Miami Lakes Medical Research, Miami Lakes, Florida, United States
🇺🇸Artemis Institute for Clinical Research, San Diego, California, United States
🇺🇸Research Centers of America, Hollywood, Florida, United States
Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05694533
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
- Conditions
- Interventions
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 785
- Registration Number
- NCT04995029
- Locations
- 🇺🇸
Pahl Pharmaceutical Professionals LLC, Oklahoma City, Oklahoma, United States
🇺🇸Prisma Health ITOR Research Pharmacy, Greenville, South Carolina, United States
🇺🇸Monroe Biomedical Research, Monroe, North Carolina, United States
Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder
- Conditions
- Interventions
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT04976855
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
🇺🇸InSite Clinical Research, DeSoto, Texas, United States
🇺🇸Johns Hopkins University School of Medicine BPRU, Baltimore, Maryland, United States
An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term
- First Posted Date
- 2020-10-06
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 216
- Registration Number
- NCT04577144
- Locations
- 🇺🇸
Addiction Recovery Research Center and Fralin Biomedical Research Institute, Roanoke, Virginia, United States